Diabetes and hypertension: the bad companions (Q38033768)

27 August 2017

title

Diabetes and hypertension: the bad companions (English)

1 reference

27 August 2017

main subject

arterial hypertension

0 references

1

Ele Ferrannini

1 reference

27 August 2017

William C Cushman

2

1 reference

27 August 2017

language of work or name

English

0 references

publication date

1 August 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

380

1 reference

27 August 2017

issue

9841

1 reference

27 August 2017

page(s)

601-610

1 reference

Early disturbances of ambulatory blood pressure load in normotensive type I diabetic patients with microalbuminuria

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Temporal patterns in overweight and obesity in Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Multivariate analysis of the relationship of six variables to blood pressure: Findings from Chicago Community Surveys, 1965–1971

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Abnormal glucose tolerance and hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Insulin resistance, insulin response, and obesity as indicators of metabolic risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Greater effect of glycemia on incidence of hypertension in women than in men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Prevalence of hypertension and associated risk factors among diabetic individuals. The Three-City Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Diabetes and hypertension in a community of older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Heritabilities of liability to diabetes when sex and age at onset are considered

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Relation between blood pressure, weight, and plasma sugar and serum insulin levels in schoolchildren aged 9-12 years in Westland, Holland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Glucose tolerance and blood pressure: long term follow up in middle aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Metabolic characteristics of prehypertension: role of classification criteria and gender.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Cardiovascular disease risk factors, type 2 diabetes mellitus, and the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Visceral fat in hypertension: influence on insulin resistance and beta-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fat.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Hypertension in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Disparate cardiovascular effects of obesity and arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Insulin resistance in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Impaired insulin action on skeletal muscle metabolism in essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Renovascular hypertension and insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Insulin-induced vasodilatation: physiology or pharmacology?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Oxidative Stress and Diabetic Complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Effect of Insulin on Acetylcholine-Induced Vasodilation in Normotensive Subjects and Patients With Essential Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Vascular function, insulin resistance and fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Insulin Sensitivity, Vascular Reactivity, and Clamp-Induced Vasodilatation in Essential Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Insulin sensitivity in familial hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Effect of Vitamin C on Forearm Blood Flow and Glucose Metabolism in Essential Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Insulin resistance and vasodilation in essential hypertension. Studies with adenosine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Serum-insulin in essential hypertension and in peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

High blood pressure and insulin resistance: influence of ethnic background

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Parental history of diabetes is associated with increased cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Clustering of cardiovascular risk factors in confirmed prehypertensive individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Salt-sensitive blood pressure and exaggerated vascular reactivity in the hypertension of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Effect of insulin on renal sodium and uric acid handling in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Thiazide and loop diuretics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Insulin prolongs the QTc interval in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Local insulin infusion stimulates expression of plasminogen activator inhibitor-1 and tissue-type plasminogen activator in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Vascular actions of insulin with implications for endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Contribution of insulin resistance to vascular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Activation of the succinate receptor GPR91 in macula densa cells causes renin release.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

High glucose and renin release: the role of succinate and GPR91.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Hyperinsulinemia does not change atherosclerosis development in apolipoprotein E null mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

2007 Guidelines for the Management of Arterial Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Blood pressure targets: are clinical guidelines wrong?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Effects of intensive blood-pressure control in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Mortality findings for stepped-care and referred-care participants in the hypertension detection and follow-up program, stratified by other risk factors. The Hypertension Detection and Follow-up Program Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Appropriate Blood Pressure Control in NIDDM (ABCD) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Cardiovascular events during differing hypertension therapies in patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT Diabetes Extension Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960987-8

7 January 2021

10.1016/S0140-6736(12)60987-8

Identifiers

DOI

1 reference

27 August 2017

1 reference